One study demonstrated that MBS improved insulin sensitivity, reduced insulin resistance (i.e., measured by HOMA-IR), and increased beta-cell compensatory capacity (i.e., measured by the Disposition Index [DI]) in patients with and without T2D. This evidence concerns the gene INS and type 2 diabetes mellitus.